drugset / Trial / NCT04724967
CeraVe Diabetes Mellitus
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of the CeraVe Diabetic Skin Line for the improvement of skin condition in patients with diabetes mellitus.
Timeline
- Start
- 2021-03-12
- Primary completion
- 2021-08-10
- Completion
- 2021-08-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CeraVe Hydrating Cleanser | Unknown | — | Topical |
| Subject | CeraVe Moisturizing Cream | Unknown | — | Topical |
Indications
No indication recorded.